A J&J unit pleaded guilty to a charge of interstate promotion of a drug, which was used for unapproved treatment of elderly dementia patients. Photo: Reuters A J&J unit pleaded guilty to a charge of interstate promotion of a drug, which was used for unapproved treatment of elderly dementia patients. Photo: Reuters
A J&J unit pleaded guilty to a charge of interstate promotion of a drug, which was used for unapproved treatment of elderly dementia patients. Photo: Reuters

Johnson & Johnson to pay US$2.2 billion to settle US allegations of fraud and kickbacks

A J&J unit pleaded guilty to a charge of interstate promotion of a drug, which was used for unapproved treatment of elderly dementia patients. Photo: Reuters A J&J unit pleaded guilty to a charge of interstate promotion of a drug, which was used for unapproved treatment of elderly dementia patients. Photo: Reuters
A J&J unit pleaded guilty to a charge of interstate promotion of a drug, which was used for unapproved treatment of elderly dementia patients. Photo: Reuters
READ FULL ARTICLE